Allergy Vaccine Market by Allergy Type (Allergic Asthma, Cat Dander Allergy, Grass Pollen Hypersensitivity), Vaccine Type (Cat Allergy Vaccine, House Dust Mite Allergy Vaccine, Injectable MPL Allergy Vaccine), Application, End User - Global Forecast 2024-
Allergy Vaccine Market by Allergy Type (Allergic Asthma, Cat Dander Allergy, Grass Pollen Hypersensitivity), Vaccine Type (Cat Allergy Vaccine, House Dust Mite Allergy Vaccine, Injectable MPL Allergy Vaccine), Application, End User - Global Forecast 2024-2030
The Allergy Vaccine Market size was estimated at USD 1.28 billion in 2023 and expected to reach USD 1.43 billion in 2024, at a CAGR 11.51% to reach USD 2.75 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Allergy Vaccine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Allergy Vaccine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Allergy Vaccine Market, highlighting leading vendors and their innovative profiles. These include ALK-Abelló, Inc., Allergy Therapeutics PLC, Angany Inc., Astellas Pharma Inc., Biomay AG, DBV Technologies SA, Enesi Pharma Limited, Immunomic Therapeutics, Inc., Jubilant Pharma Limited, LETI Pharma, S.L.U., Merck & Co., Inc., Novartis AG, Sementis Ltd., Stallergenes Greer International AG, Sunstone by Anergis SA, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
This research report categorizes the Allergy Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:
Allergy Type
Allergic Asthma
Cat Dander Allergy
Grass Pollen Hypersensitivity
Peanut Hypersensitivity
Seasonal Allergic Rhinitis
Tree Pollen Hypersensitivity
Vaccine Type
Cat Allergy Vaccine
House Dust Mite Allergy Vaccine
Injectable MPL Allergy Vaccine
Peanut Allergy Vaccine
Ragweed Allergy Immunotherapy Vaccine
Application
HIV
Oncology
Respiratory
End User
Homecare
Hospitals
Specialty Clinics
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom The report offers valuable insights on the following aspects:
Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
What is the market size and forecast of the Allergy Vaccine Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Allergy Vaccine Market?
What are the technology trends and regulatory frameworks in the Allergy Vaccine Market?
What is the market share of the leading vendors in the Allergy Vaccine Market?
Which modes and strategic moves are suitable for entering the Allergy Vaccine Market?
Note: PDF & Excel + Online Access - 1 Year
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Allergy Vaccine Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of allergies globally
5.1.1.2. Increasing air pollution with industrialization
5.1.1.3. Rising awareness among consumers about the allergies
5.1.2. Restraints
5.1.2.1. Limited allergy vaccine manufacturers
5.1.3. Opportunities
5.1.3.1. Research and development for the production of specific allergy vaccine
5.1.3.2. Government and private sector initiatives in the production of vaccines
5.1.4. Challenges
5.1.4.1. Capital intensive in the production of allergy vaccines
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Allergy Vaccine Market, by Allergy Type
6.1. Introduction
6.2. Allergic Asthma
6.3. Cat Dander Allergy
6.4. Grass Pollen Hypersensitivity
6.5. Peanut Hypersensitivity
6.6. Seasonal Allergic Rhinitis
6.7. Tree Pollen Hypersensitivity
7. Allergy Vaccine Market, by Vaccine Type
7.1. Introduction
7.2. Cat Allergy Vaccine
7.3. House Dust Mite Allergy Vaccine
7.4. Injectable MPL Allergy Vaccine
7.5. Peanut Allergy Vaccine
7.6. Ragweed Allergy Immunotherapy Vaccine
8. Allergy Vaccine Market, by Application
8.1. Introduction
8.2. HIV
8.3. Oncology
8.4. Respiratory
9. Allergy Vaccine Market, by End User
9.1. Introduction
9.2. Homecare
9.3. Hospitals
9.4. Specialty Clinics
10. Americas Allergy Vaccine Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Allergy Vaccine Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Allergy Vaccine Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. ALK-Abelló, Inc.
14.1.2. Allergy Therapeutics PLC
14.1.3. Angany Inc.
14.1.4. Astellas Pharma Inc.
14.1.5. Biomay AG
14.1.6. DBV Technologies SA
14.1.7. Enesi Pharma Limited
14.1.8. Immunomic Therapeutics, Inc.
14.1.9. Jubilant Pharma Limited
14.1.10. LETI Pharma, S.L.U.
14.1.11. Merck & Co., Inc.
14.1.12. Novartis AG
14.1.13. Sementis Ltd.
14.1.14. Stallergenes Greer International AG
14.1.15. Sunstone by Anergis SA
14.1.16. Thermo Fisher Scientific Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
FIGURE 1. ALLERGY VACCINE MARKET RESEARCH PROCESS
FIGURE 2. ALLERGY VACCINE MARKET SIZE, 2023 VS 2030